Transcat (NASDAQ:TRNS) Given New $116.00 Price Target at HC Wainwright

Transcat (NASDAQ:TRNS) had its target price upped by analysts at HC Wainwright from $106.00 to $116.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the scientific and technical instruments company’s stock. HC Wainwright’s price target suggests a potential upside of 22.93% from the stock’s current price.

Other equities analysts have also issued research reports about the stock. Oppenheimer lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. Northland Securities reiterated a “market perform” rating and set a $85.00 price objective (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, StockNews.com raised shares of Transcat from a “sell” rating to a “hold” rating in a research report on Tuesday. Four analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $114.00.

Transcat Stock Up 16.2%

NASDAQ TRNS opened at $94.36 on Wednesday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. Transcat has a fifty-two week low of $67.56 and a fifty-two week high of $147.12. The stock has a market capitalization of $878.40 million, a PE ratio of 51.01 and a beta of 0.69. The business has a fifty day moving average price of $78.33 and a two-hundred day moving average price of $89.84.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The company had revenue of $77.13 million during the quarter, compared to the consensus estimate of $76.40 million. Transcat’s revenue for the quarter was up 8.8% on a year-over-year basis. Equities analysts expect that Transcat will post 2.3 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in TRNS. Jones Financial Companies Lllp boosted its position in Transcat by 686.7% during the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock worth $37,000 after purchasing an additional 309 shares during the period. Quantbot Technologies LP purchased a new stake in shares of Transcat in the 1st quarter valued at $76,000. State of Wyoming bought a new position in shares of Transcat during the 1st quarter valued at $95,000. Aquatic Capital Management LLC raised its position in Transcat by 1,052.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company’s stock worth $122,000 after purchasing an additional 1,052 shares during the period. Finally, GAMMA Investing LLC lifted its stake in Transcat by 10,137.5% in the first quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company’s stock worth $122,000 after purchasing an additional 1,622 shares during the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.